ISSN 0717-7526 online version
ISSN 0048-766X print version

INSTRUCTIONS TO AUTHORS

Scope and policy

The manuscripts sent to the REVISTA CHILENA DE OBSTETRICIA Y GINECOLOGÍA must comply with the following instructions: It must be written in Spanish, in letter size, with margins of at least 3 cm in the 4 edges. All pages must be numbered in the upper right corner, starting with the title page. Two identical copies of the whole text must be handed, along with an identical copy for PC, on CD, with 1.5 line spacing, with font size 12 point, Arial or Times New Roman type, aligned to the left. Figures showing images must be delivered in photographic prints of excellent quality. The maximum length of Investigation Articles is 2,500 words, the Revision Articles of 3,000 words, the Clinical Cases of 1,500 words and letters to the editor of 1,000 words. At the bottom of the title page there must be a computational recount of words, counted from the beginning of the Introduction to the end of the Discussion (excluding title page, summary, acknowledgments, references, tables and figures).

Every manuscript must be sent with the AUTHORING DECLARATION which is on the last page of each issue of the journal.

ORIGINAL ARTICLES

Articles must be original and unpublished. The order of the sections of the article must start in new pages and will be as follows:
1.
TITLE: The first page of the manuscript should contain the title of the work. It should be concise but informative about the matter of their publication. The authors are identified by their first name, last name and initial of the mother’s last name. After each name you must identify with superscript numbers the name of the Department, Service and Institution to which the person belongs. Please specify in superscript lowercase letters the authors who are not medical doctors, identifying his or her profession or student level. At the bottom of this page the name and address of the corresponding author must be written indicating the fax, phone and e-mail. Computational counting of words goes at the end of this page.
2.
SUMMARY and KEYWORDS: The second page should contain a summary in Spanish and English, not exceeding 250 words (each), describing the purposes, the material and method, the main results and major conclusions. Authors should propose 3 to 10 keywords.
3.
INTRODUCTION. Brief description of the objectives of the research and literature strictly related to the study. Limit your extension, if possible, to no more than 200 words.
4.
MATERIAL AND METHODS. Describe the selection of patients, experimental animals or tissues and their respective controls. Indicate the number of cases or observations, the statistical methods used and the level of significance chosen. If the study includes humans or animals, state whether the investigation was approved by the appropriate ethics committee of the Institution.
5.
RESULTS. Present results on a logical and consistent form to the text, tables and figures. Do not duplicate data on tables and figures. In the text highlight the important points without repeating data presented in tables and figures. Do not argue the results in this section.
6.
DISCUSSION. Discuss the results of the investigation but do not write a review of the topic. Do not repeat detailed information already on RESULTS. State matches or mismatches of the results with other studies. Connect your findings with the purposes of the study in the INTRODUCTION. Avoid making conclusions that are not supported by the results. Propose recommendations when appropriate.
7.

 

REFERENCE. Limit your references to the most relevant. Number them in the order they appear in the text, identified by arabic numerals in parentheses at the end of the sentence or paragraph on which they appear. The annotation of each reference should be as follows:
a)
Journal articles. Complete list of authors if six or less, and followed by "et al" if more than 6. Followed by the full title of the article in its original language. Then the name of the journal (according abbreviated style used in the Index Medicus) and year of publication, volume, initial and final page of the article. Example: Bianchi M, Berrios C, Villaseca P, Arteaga E. Endometrial pathology in women with abnormal bleeding during hormone replacement therapy. Rev Chil Obstet Ginecol 2003; 68(6): 487 - 490.
b)
Chapters in books. Complete list of authors. Chapter title. Complete list of publishers. Title of the text, edition number, city and publisher’s name, year of publishing, initial and final page of the chapter. Example: Belizan JM, Villar J, Althabe F, Carroli G. Fetal growth retardation. In: Perez A, Donoso E (eds). OBSTETRICS. 3rd ed. Santiago: Editorial MEDITERRANEO, 1999, 532-544.
c)
Other sources. Material on the Internet:

a. Sites: Canadian Perinatal Health Report, 2000. Arbuckle T, Dzakpasu S, Liu S, Rouleau J, Rusen ID, Turner L, Wu Wen S. Found in:
www.hc-sc.gc.ca/hpb/lcdc/brch/reprod.html. Accessed January 20, 2004.

b. Journal articles: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [journal online] 1995. Jan-Mar [cited 1996, Jun 5]; 1(1):[24 screens]. Found in: URL: http://www.cdc.gov/ncidod/EID/eid.htm
Authors are responsible for the accuracy of their references.
8.
Tables, Figures and Illustrations. They must be original and unpublished. Identify figures in arabic numerals and tables in roman numerals. Submit them in separate sheets. The photomicrographs should approach only the site of interest. Reproductions of X-rays should be in positive. Every graphic illustration must report their position on the back, the identification of the author and the study. The scanned images should come on separate CDs, with its format and resolution clearly stated on their labels. Tables and figures should have a title that clearly expresses the content. Figures in colour will be of authors cost. The drugs should be designated by their generic name and not by its trade name.

CLINICAL CASES

Will be accepted those exceptional cases that present a scientific contribution according to international standards. Should not include a review of the literature.

DOCUMENTS (Reviews)

Their goal is to provide current concepts and developments on important topics of OBGYN or related matters. The extension of the articles must be equal to the original articles, but the order of sections may vary. The Editing Committee reserves the right to reduce the length of the articles, amend its submission and review the order. The corresponding author will receive the edited version for approval by e-mail. The right to refuse work or to ask the authors any necessary changes is also reserved. The ideas, opinions and conclusions expressed in articles are solely the responsibility of the authors. Authors are advised to read the instructions established by the International Committee of Medical Journal (ICMJE), translated into Spanish by the Pan American Health Organization and published in the Pan American Journal of Public Health (Public Health Rev Panam 2004;15(1):41-57), the original English version is in www.icmje.org.

The Revista Chilena de Obstetricia y Ginecología supports the policies for the registration of clinical trials of the World Health Organization (WHO) and the International Committee of Medical Journal (ICMJE), recognizing the importance of such initiatives for the international registration and disclosure information on clinical trials, in open access. Consequently only be accepted for publication, from 2007, the articles of clinical investigations, which have received an identification number on one of the registers of clinical trials validated by the criteria established by WHO and ICMJE, whose addresses are available on the ICMJE site (www.icmje.org). The identification number must be stated at the end of the summary.

Authorship

STATEMENT OF AUTHORSHIP LIABILITY

The following document should be completed by all the authors of manuscripts.
MANUSCRIPT TITLE:


STATEMENT: I certify that I have directly contributed to the intellectual content of this manuscript, the genesis and analysis of its data, so I am able to be publicly responsible for it and I accept that my name appears on the list of authors. In the column "Code of Participation" I personally write all the letters of codes that designate or identify my participation in this work, chosen from the list below:

a) Planning and design work.
b) Collection of data.
c) Analysis and interpretation of results.
d) Writing of the manuscript.
e) Critical review of the manuscript.
f) Approval of the final version.
g) Provision of study materials or patients.
h) Obtaining funding.
i) Statistics advising.
j) Technical or administrative advising.
k) Other contributions (define).

Conflict of interest: NO: YES: (Explain):



NAME AND SIGNATURE OF EACH AUTHOR
CODES OF PARTICIPATION
















Sending of manuscripts

All correspondence should be sent to the Chief Editor at the following addresses:

  • Revista Chilena of Obstetricia y Ginecología
    Román Díaz #205, Dep. 205 Providencia
    Santiago de Chile
    Phone: 56-2-2235 0133
    Fax: 56-2-2235 1294
    E-mail: sochog@entelchile.net
    Web site: www.sochog.cl

[About the journal] [Editorial Board] [Subscription]


Sociedad Chilena de Obstetricia y Ginecología

Román Díaz #205, Depto. 205, Providencia
Santiago - Chile
Tel.: (56-2) 2235 0133
Fax: (56-2) 2235 1294


sochog@entelchile.net